Nootropics Index - Save on smarter supplements
Amino acids & derivatives

GABA

gamma-aminobutyric acid (GABA)

GABA is gamma-aminobutyric acid, a non-protein amino acid and the main inhibitory neurotransmitter in the human central nervous system. As a supplement, the cited human evidence on this page is limited for stress and calming markers and very limited for overnight rest outcomes. Compare milligrams per serving, product form and matrix, combination ingredients, and blood-pressure context.

CalmRelaxationSleep SupportStress ResilienceGabaergicFermentedFood Derived
Updated August 2026/5 min read/7 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

What it is

2

GABA is gamma-aminobutyric acid, a four-carbon non-protein amino acid. In the body it functions as the main inhibitory neurotransmitter, but supplement claims should not assume that swallowing GABA directly changes brain signaling in the same way as endogenous GABA.

Evidence position2
The practical page framing is stress/rest support with limited evidence, not a broad cognition or mood-enhancement page. Mechanism language should stay separate from proven user outcomes.
02

Names, aliases and forms

AbbreviationGABA
Chemical Namesgamma-aminobutyric acid; 4-aminobutanoic acid; gamma-aminobutyrate
Cas Number56-12-2
Pubchem Cid119
03

Potential effects and evidence map

A 2020 systematic review found limited human evidence for stress outcomes and very limited evidence for overnight rest outcomes after oral GABA. Small trials report EEG relaxation markers or bedtime-rest changes, but methods, doses, populations, and products vary. The cited human evidence base is too heterogeneous to support a broad nootropic profile.

Effect domainMagnitudeGrade
Calm / relaxation2
AcuteConfidence: Medium

Oral GABA has limited human evidence for acute relaxation and stress-marker support.

Note Small human studies report EEG or stress-marker changes, but sample sizes and methods limit confidence.

2/5
C
Stress resilience2
AcuteConfidence: Medium

Stress-related findings are plausible but still limited and product-dependent.

Note The systematic review considered stress evidence limited, not definitive.

2/5
C
Sleep quality2
CumulativeConfidence: Low

The systematic review found very limited evidence for sleep outcomes after oral GABA, mainly in small repeated-use studies.

Note The review describes early sleep measures in studies lasting 1-8 weeks; product forms and methods varied.

1/5
C
04

Typical dosages and timing

Typical
100-300 mg/day
Not a recommendation
Lower bound
100 mg
Profile value
Upper bound
300 mg
Profile value
Human-study context2100-300 mg/day

In the systematic review, biosynthetic GABA sleep studies used 100-300 mg for 1-8 weeks. This is a study-context descriptor, not a personalized dose target or a universal dose across all forms.

Label amounts vary545-3000 mg/day

The USP safety review noted a wide range of label serving amounts in U.S. supplement listings. A higher label amount should not be read as stronger evidence.

05

Timing & effect horizon

Effect horizonAcute + cumulative
AcuteCumulative
Peak3Acute
30 min
Study window2Cumulative
1-8 weeks
Blood-level peak3

One human absorption study reported peak blood GABA around 30 minutes after oral intake. This does not prove central nervous system delivery or a predictable user effect.

Acute marker window4

A small EEG study measured relaxation-marker changes about 60 minutes after intake. Interpret this as an acute marker context, not as a duration claim.

06

Safety, side effects and risk profile

Blood-pressure context5
The USP review noted that some studies found a transient and moderate blood pressure drop. Be cautious if blood pressure is already low, actively monitored, or affected by anti-hypertensive drugs.
Pregnancy and lactation5
The USP review found no available human data for pregnancy or lactation. Because GABA is a neurotransmitter-related compound and may affect endocrine markers, this is a qualified-clinician review context rather than a casual supplement choice.
Sedation / impairment5
Confidence: Low

Drowsiness was reported in the reviewed safety literature; direct evidence for functional impairment from oral GABA is limited.

Note USP did not establish a specific sedative-product interaction; the qualified medication concern in this profile is hypotension with antihypertensive drugs.

1/5
C
Cardiovascular caution5
Confidence: Medium

Some studies noted a small temporary blood pressure drop, so extra caution is warranted if pressure is low or monitored.

Note The USP review specifically cautions about possible additive hypotension risk with anti-hypertensive drugs.

2/5
C
GI discomfort5
Confidence: Low

Mild or moderate abdominal discomfort was reported in some clinical contexts; rates were not consistently established across product forms.

Note Reviewed studies ranged from single exposure to 12 weeks.

1/5
C
Headache / dizziness5
Confidence: Low

Headache or dizziness was reported in the reviewed safety literature, with low certainty about frequency across products.

Note The safety review did not establish consistent ingredient-specific rates.

1/5
C
Legal / regulatory risk6
Confidence: Medium

U.S. supplement availability does not mean FDA approval for disease or clinical outcome claims.

Note Allowed claims vary by jurisdiction and label wording.

1/5
C
Reported tolerability context5

USP did not identify serious adverse events in the reviewed clinical studies, but it describes reports of drowsiness, mild or moderate abdominal discomfort, headache, dizziness, and transient throat burning. The frequency and cause of these effects were not consistently established across heterogeneous products.

08

How it compares

Why study results are hard to compare2

Trials use different products, doses, food matrices, populations, and outcome measures. Some use pure capsules, while others use fermented foods, beverages, or combination formulas. This makes product-source and ingredient-panel review more useful than assuming all GABA listings match the same evidence base.

A recent fermented-extract study7

A 2026 randomized, double-blind trial evaluated a fermented rice-germ extract enriched with GABA for 8 weeks, rather than an isolated GABA product. Its findings cannot establish equivalent outcomes for every GABA powder or capsule.

09

Practical buying and quality notes

  • Compare GABA mass per serving, capsule versus powder format, pure GABA versus GABA-containing fermented-food extracts, combination ingredients such as theanine or melatonin, testing/COA availability, and the form-specific normalized price when available: per gram for powders and per capsule or serving for capsules. Be careful with blends that hide the actual GABA amount.2
10

FAQ

Is GABA a nootropic?

2

Not in the usual cognition-focused sense. This page examines oral GABA limited stress/rest evidence; it does not establish a broad cognitive or mood profile.

What GABA dosage is most evidence-based?

2

The profile card and Human-study context row summarize the most useful studied-dose range. Compare a product label with the cited study form and duration rather than assuming a higher label amount has stronger evidence.

How long does GABA take to work?

3

Human data suggest blood levels can peak around 30 minutes, while one small EEG study measured relaxation-marker changes around 60 minutes. That is an onset context, not a predictable effect or duration claim.

Is GABA useful before bed?

2

Small studies and the systematic review include bedtime-rest outcomes, but the review still judged the evidence as very limited. Compare it as a cautious rest-support option, not as a proven nightly protocol.

Does oral GABA cross the blood-brain barrier?

2

The answer is still debated. Product marketing often jumps from GABA neurotransmitter biology to brain-effect claims, but oral effects may involve peripheral pathways or indirect mechanisms rather than simple direct brain delivery.

11

References

  1. PubChem Compound Summary for CID 119, gamma-aminobutyric acid.
  2. Hepsomali P, Groeger JA, Nishihira J, Scholey A. Effects of Oral Gamma-Aminobutyric Acid (GABA) Administration on Stress and Sleep in Humans: A Systematic Review. Front Neurosci. 2020.
  3. Yamatsu A, Yamashita Y, Pandharipande T, Maru I, Kim M. Effect of oral gamma-aminobutyric acid (GABA) administration on sleep and its absorption in humans. Food Sci Biotechnol. 2016.
  4. Abdou AM, Higashiguchi S, Horie K, Kim M, Hatta H, Yokogoshi H. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors. 2006.
  5. Oketch-Rabah HA, Madden EF, Roe AL, Betz JM. United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA). Nutrients. 2021.
  6. U.S. Food and Drug Administration. Dietary Supplements: Information for Consumers.
  7. Effects of GABA-enriched rice germ extract fermented by Lactobacillus brevis BJ20 on stress symptoms and related biomarkers in adults: a randomized, double-blind, placebo-controlled trial. Journal of Functional Foods. 2026;138:107183.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.